Insider Transactions in Q4 2020 at Vyne Therapeutics Inc. (VYNE)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,656
-0.73%
|
$9,656
$1.58 P/Share
|
|
Dec 31
2020
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,822
-0.56%
|
$1,822
$1.58 P/Share
|
|
Dec 31
2020
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,378
-0.82%
|
$2,378
$1.58 P/Share
|
|
Dec 31
2020
|
Matthew T. Wiley Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,541
-0.43%
|
$1,541
$1.58 P/Share
|
|
Dec 03
2020
|
Patrick G Lepore Director |
BUY
Open market or private purchase
|
Direct |
50,000
+50.0%
|
$50,000
$1.71 P/Share
|
|
Nov 30
2020
|
David Domzalski PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,263
+0.32%
|
$4,263
$1.45 P/Share
|
|
Nov 30
2020
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
BUY
Grant, award, or other acquisition
|
Direct |
10,460
+3.09%
|
$10,460
$1.45 P/Share
|
|
Nov 30
2020
|
Matthew T. Wiley Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,838
+2.14%
|
$7,838
$1.45 P/Share
|